先天性膈疝胎儿手术的随机气管封堵加速肺发育(TOTAL)试验:基于合并数据的再分析
合并两项随机试验的287例胎儿(中度肺发育不良196例、重度91例)个体数据再分析,比较胎儿镜下腔内气管封堵与期待管理的结局。气管封堵与出院存活率升高相关(校正OR 1.78,95%CI 1.05-3.01),早期球囊置入额外效应不确定(校正OR 1.53,95%CI 0.60-3.91),且早期置入者分娩平均提前3.2周(95%CI 2.3-4.1)。
要点
- 气管封堵与中、重度肺发育不良胎儿出院存活率升高相关(校正OR 1.78,95%CI 1.05-3.01)。
- 早期球囊置入的额外效应不确定(校正OR 1.53,95%CI 0.60-3.91,P=.370)。
- 早期球囊置入者分娩平均提前3.2周(95%CI 2.3-4.1)。
核心结论
- 本分析提示胎儿镜下腔内气管封堵可提高中度和重度肺发育不良胎儿的存活率。
- 两项TOTAL试验结果分别考虑时的差异可能源于球囊置入时间点不同,但该时间点效应无法可靠评估,原因包括样本量小和疾病严重度的混杂效应。
- 早期球囊置入的胎儿镜下腔内气管封堵尤其强烈增加早产风险。
研究设计与样本
- 对两项随机试验的个体参与者数据进行再分析,2008年至2020年在14个胎儿镜下腔内气管封堵经验中心评估,按1:1随机分为期待管理或胎儿镜下腔内气管封堵,均接受标准化产后管理。
- 合并数据共287例患者(中度肺发育不良196例,重度肺发育不良91例)。
- 主要终点为从新生儿重症监护室出院时存活;次要终点为6月龄存活、6月龄无氧依赖存活及活产时孕周。
- 采用惩罚回归,协变量包括干预(胎儿镜下腔内气管封堵 vs 期待管理)、早期球囊置入(是 vs 否)、观察与预期肺头比、肝脏疝入(是 vs 否)及试验(重度 vs 中度)。
- 评估干预与观察与预期肺头比的交互作用以研究治疗效果异质性。
主要发现
- 出院存活率:胎儿镜下腔内气管封堵的校正比值比为1.78(95%CI 1.05-3.01,P=.031)。
- 早期球囊置入的额外效应高度不确定:校正比值比1.53(95%CI 0.60-3.91,P=.370)。
- 合并两效应后,早期球囊置入的胎儿镜下腔内气管封堵校正比值比为2.73(95%CI 1.15-6.49)。
- 6月龄存活及6月龄无氧依赖存活的结果与主要终点相当。
- 分娩孕周:晚期置入者较期待管理平均提前1.7周(95%CI 1.1-2.3),早期置入者平均提前3.2周(95%CI 2.3-4.1)。
关键数值与推荐
- 重度肺发育不良:胎儿镜下腔内气管封堵于孕27+0至29+6周(「早期」)进行;中度肺发育不良于孕30+0至31+6周(「晚期」)进行。
- 中度肺发育不良出院存活率绝对增加13%(95%CI -1至28,P=.059);重度肺发育不良绝对增加25%(95%CI 6至46,P=.0091)。
临床怎么用
- 本分析提示胎儿镜下腔内气管封堵可提高中度和重度肺发育不良胎儿的存活率。
- 早期球囊置入尤其强烈增加早产风险,但其额外效应无法可靠评估。
- 原文未据此给出推荐。
局限性
- 球囊置入时间点的效应无法可靠评估,原因包括样本量小和疾病严重度的混杂效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two randomized controlled trials compared the neonatal and infant outcomes after fetoscopic endoluminal tracheal occlusion with expectant prenatal management in fetuses with severe and moderate isolated congenital diaphragmatic hernia, respectively. Fetoscopic endoluminal tracheal occlusion was carried out at 27+0 to 29+6 weeks' gestation (referred to as "early") for severe and at 30+0 to 31+6 weeks ("late") for moderate hypoplasia. The reported absolute increase in the survival to discharge was 13% (95% confidence interval, -1 to 28; P=.059) and 25% (95% confidence interval, 6-46; P=.0091) for moderate and severe hypoplasia. OBJECTIVE: Data from the 2 trials were pooled to study the heterogeneity of the treatment effect by observed over expected lung-to-head ratio and explore the effect of gestational age at balloon insertion. STUDY DESIGN: Individual participant data from the 2 trials were reanalyzed. Women were assessed between 2008 and 2020 at 14 experienced fetoscopic endoluminal tracheal occlusion centers and were randomized in a 1:1 ratio to either expectant management or fetoscopic endoluminal tracheal occlusion. All received standardized postnatal management. The combined data involved 287 patients (196 with moderate hypoplasia and 91 with severe hypoplasia). The primary endpoint was survival to discharge from the neonatal intensive care unit. The secondary endpoints were survival to 6 months of age, survival to 6 months without oxygen supplementation, and gestational age at live birth. Penalized regression was used with the following covariates: intervention (fetoscopic endoluminal tracheal occlusion vs expectant), early balloon insertion (yes vs no), observed over expected lung-to-head ratio, liver herniation (yes vs no), and trial (severe vs moderate). The interaction between intervention and the observed over expected lung-to-head ratio was evaluated to study treatment effect heterogeneity. RESULTS: For survival to discharge, the adjusted odds ratio of fetoscopic endoluminal tracheal occlusion was 1.78 (95% confidence interval, 1.05-3.01; P=.031). The additional effect of early balloon insertion was highly uncertain (adjusted odds ratio, 1.53; 95% confidence interval, 0.60-3.91; P=.370). When combining these 2 effects, the adjusted odds ratio of fetoscopic endoluminal tracheal occlusion with early balloon insertion was 2.73 (95% confidence interval, 1.15-6.49). The results for survival to 6 months and survival to 6 months without oxygen dependence were comparable. The gestational age at delivery was on average 1.7 weeks earlier (95% confidence interval, 1.1-2.3) following fetoscopic endoluminal tracheal occlusion with late insertion and 3.2 weeks earlier (95% confidence interval, 2.3-4.1) following fetoscopic endoluminal tracheal occlusion with early insertion compared with expectant management. There was no evidence that the effect of fetoscopic endoluminal tracheal occlusion depended on the observed over expected lung-to-head ratio for any of the endpoints. CONCLUSION: This analysis suggests that fetoscopic endoluminal tracheal occlusion increases survival for both moderate and severe lung hypoplasia. The difference between the results for the Tracheal Occlusion To Accelerate Lung growth trials, when considered apart, may be because of the difference in the time point of balloon insertion. However, the effect of the time point of balloon insertion could not be robustly assessed because of a small sample size and the confounding effect of disease severity. Fetoscopic endoluminal tracheal occlusion with early balloon insertion in particular strongly increases the risk for preterm delivery.
引用
- Van Calster B, Benachi A, Nicolaides KH, et al. The randomized Tracheal Occlusion To Accelerate Lung growth (TOTAL)-trials on fetal surgery for congenital diaphragmatic hernia: reanalysis using pooled data. Am J Obstet Gynecol. 2021. PMID: 34808130. doi:10.1016/j.ajog.2021.11.1351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。